Latest News
By Eze Castle Integration – Operational due diligence has become a hot topic that continues to gain importance and attention throughout the alternative investment industry. Over the past few years, as regulations have evolved and investors increasingly seek transparency, financial firms are spending more time than ever preparing for the due diligence process.
It is no surprise that the investment industry landscape is becoming more and more competitive. As this trend continues, investors are raising their expectations and looking towards firms that display the highest levels in operational excellence. One important way to ensure your firm meets these high standards
By Eze Castle Integration – Investment risk plays an important role in the life of a hedge fund manager, but technology risk should not. When it comes to your firm’s technology systems and operations, you want things to run efficiently, not add more stress to your already crowded plate.
Mitigating technology risk is a critical step to ensuring your hedge fund operates smoothly and successfully. Following are a few areas to keep in mind as you evaluate your firm’s technology risk:
Layers of redundancy
One way to reduce your firm’s technology risk is to add layers of redundancy throughout your
Crayhill Capital Management LP, an alternative asset management firm that specialises in private credit investments, has appointed Stefan Hoefer as Managing Director.
Hoefer will be a senior member of Crayhill’s investment team. His responsibilities will include helping to source, underwrite, structure, execute and manage private credit investments.
“We are gaining immediate traction by bringing on Stefan, who we have worked closely with in the past. His special situations, restructuring and fundamental credit investment skills are exceptional and will help to better position the firm as we head further into the credit cycle,” says Carlos Mendez, Co-Founder and Managing Partner at
Rock Rail and Aberdeen Standard Investments (ASI) have finalised an agreement to fund, purchase and then lease new fleets of trains across Europe.
Rock Rail and ASI together have already successfully financed and procured modern train fleets for three UK rail networks – a total investment of GBP2 billion. The new joint venture (JV) will draw on that expertise to focus on private financing solutions tailored for rail networks in Continental Europe and Scandinavia.
In the UK, Rock Rail and ASI have been credited with transforming the market for the procurement of trains (rolling stock). The ‘Rock ASI’ approach
Gide has advised Legrand on its purchase of Shenzhen Clever Electronic Co, a Chinese specialist in intelligent PDUs4 for data centres.
Shenzhen Clever Electronic Co rounds out Legrand’s product offerings in a high added-value segment, where it is already number one in the United States with its Raritan and Server Technology brands.
Gide advised Legrand on all aspects of the project, including legal due diligence, structuring, and negotiation and drafting of the transaction documents.
The Gide team was headed by partner David Boitout, working with Wang Zengyan and Li Jing, associates.
Ecura Helse og Omsorg (Ecura), a portfolio company of Longship Fund I, has made two new add-on acquisitions – Asor Helse and Accurate Care.
Asor Helse is a provider of home care and health services in the Norwegian market, with a focus on elderly care, personal assistance to disabled, and home health care. Accurate Care provides temporary staff for hire and qualified health personnel for permanent employment to the Norwegian health and care market. Asor Helse and Accurate Care had revenues of NOK118 million and NOK65 million, respectively in 2017.
Both companies have enjoyed solid growth in their respective
Blue Ox Healthcare Partners (Blue Ox), an investment firm focused on providing growth capital to healthcare companies in the middle market, has led a USD52 million Series E investment in Epic Sciences (Epic), a diagnostics company developing solutions to personalise and advance cancer treatment and management.
Proceeds from the fundraising round are expected to be used to accelerate Epic’s clinical studies for oncology decision support services in its pipeline and execution of its long-term growth plan.
Based in San Diego, Epic is transforming late-stage cancer treatment by applying computer vision and machine learning techniques to match patients’ individual cancer
White Oak Global Advisors has held the close of the White Oak Yield Spectrum Fund to outside investors, with approximately USD2.1 billion of total commitments, exceeding the USD1.75 billion fundraising target.
White Oak’s previous flagship fund, the White Oak Summit Fund, closed with approximately USD1.3 billion of commitments in March 2016.
The capital for the White Oak Yield Spectrum Fund was raised from a diversified group of institutional investors worldwide. In particular, the Fund attracted very strong support from public and private pension funds, insurance companies and global family offices. White Oak currently manages over USD5.6 billion of committed
Ultimus Fund Solutions, an independent provider of mutual fund, private fund, pooled investment and middle office services, has completed the integration and brand transition of Woodfield Fund Administration, following the acquisition of the private fund administration firm in April.
As a result, Ultimus has expanded its offering to include fund administration services for various private fund structures such as private equity, venture capital, real estate and hedge funds.
As a fully integrated firm, Ultimus is able to better leverage technology investments, resources and assets, providing current and prospective clients the opportunity to access a wider range of services from
Innovia Medical (Innovia), Shore Capital Partners’ specialty surgical products platform, has acquired with Eagle Laboratories (Eagle Labs), a manufacturer and distributor of ophthalmic products, focusing on single-use cannula, micro-surgical knives, and blades.
“Since their founding over 28 years ago, Eagle Labs has established themselves as a best-in-class supplier of ophthalmic cannula, knives, and blades, becoming a trusted partner and market leader in the industry. We are impressed with what the De Camp family and their team have accomplished and are excited to partner with them in the next stage of growth,” says Terry Meredith, Chief Executive Officer of Innovia.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
